ATE280578T1 - Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol - Google Patents
Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherolInfo
- Publication number
- ATE280578T1 ATE280578T1 AT98966615T AT98966615T ATE280578T1 AT E280578 T1 ATE280578 T1 AT E280578T1 AT 98966615 T AT98966615 T AT 98966615T AT 98966615 T AT98966615 T AT 98966615T AT E280578 T1 ATE280578 T1 AT E280578T1
- Authority
- AT
- Austria
- Prior art keywords
- tocopherol
- combination
- retinoic acid
- acid metabolism
- metabolism blocking
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97204019 | 1997-12-19 | ||
PCT/EP1998/008127 WO1999032098A2 (en) | 1997-12-19 | 1998-12-12 | Combination of a ramba and a tocopherol |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE280578T1 true ATE280578T1 (de) | 2004-11-15 |
Family
ID=8229088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98966615T ATE280578T1 (de) | 1997-12-19 | 1998-12-12 | Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol |
Country Status (11)
Country | Link |
---|---|
US (1) | US6265425B1 (de) |
EP (1) | EP1037629B1 (de) |
JP (1) | JP2001526215A (de) |
AT (1) | ATE280578T1 (de) |
AU (1) | AU2413399A (de) |
DE (1) | DE69827295T2 (de) |
DK (1) | DK1037629T3 (de) |
ES (1) | ES2232034T3 (de) |
PT (1) | PT1037629E (de) |
SI (1) | SI1037629T1 (de) |
WO (1) | WO1999032098A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US7636680B2 (en) * | 2001-10-03 | 2009-12-22 | Starmine Corporation | Methods and systems for measuring performance of a security analyst |
WO2003053411A1 (en) | 2001-12-19 | 2003-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
WO2005003100A2 (en) * | 2003-07-03 | 2005-01-13 | Myriad Genetics, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
MX2008009215A (es) | 2006-01-17 | 2008-12-10 | Barrier Therapeutics Inc | Tratamiento de trastornos inflamatorios con compuestos de triazol. |
JP2009527560A (ja) * | 2006-02-21 | 2009-07-30 | アムゲン インコーポレイティッド | ホスホジエステラーゼ10阻害剤としてのシンノリン誘導体 |
EP2491928A2 (de) * | 2007-10-19 | 2012-08-29 | The University of Tokyo | Therapeutikum für Vitiligo und Verfahren zur Beschleunigung der Pigmentierung |
-
1998
- 1998-12-12 AU AU24133/99A patent/AU2413399A/en not_active Abandoned
- 1998-12-12 ES ES98966615T patent/ES2232034T3/es not_active Expired - Lifetime
- 1998-12-12 SI SI9830728T patent/SI1037629T1/xx unknown
- 1998-12-12 WO PCT/EP1998/008127 patent/WO1999032098A2/en active IP Right Grant
- 1998-12-12 JP JP2000525089A patent/JP2001526215A/ja not_active Withdrawn
- 1998-12-12 DE DE69827295T patent/DE69827295T2/de not_active Expired - Fee Related
- 1998-12-12 EP EP98966615A patent/EP1037629B1/de not_active Expired - Lifetime
- 1998-12-12 US US09/581,891 patent/US6265425B1/en not_active Expired - Fee Related
- 1998-12-12 DK DK98966615T patent/DK1037629T3/da active
- 1998-12-12 AT AT98966615T patent/ATE280578T1/de not_active IP Right Cessation
- 1998-12-12 PT PT98966615T patent/PT1037629E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
AU2413399A (en) | 1999-07-12 |
WO1999032098A3 (en) | 1999-08-19 |
ES2232034T3 (es) | 2005-05-16 |
EP1037629A2 (de) | 2000-09-27 |
JP2001526215A (ja) | 2001-12-18 |
US6265425B1 (en) | 2001-07-24 |
EP1037629B1 (de) | 2004-10-27 |
DK1037629T3 (da) | 2005-03-07 |
PT1037629E (pt) | 2005-03-31 |
DE69827295T2 (de) | 2006-02-09 |
SI1037629T1 (en) | 2005-04-30 |
DE69827295D1 (de) | 2004-12-02 |
WO1999032098A2 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
BRPI0411255A (pt) | composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto | |
SE9703191D0 (sv) | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases | |
TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
DK0650483T3 (da) | (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
WO2004089380A3 (en) | Pharmaceutical use of fused 1,2,4-triazoles | |
ATE79619T1 (de) | Arzneimittel. | |
AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
YU49026B (sh) | UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE | |
MY123193A (en) | Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same | |
ATE280578T1 (de) | Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
CA2215470A1 (fr) | Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
WO1998009599A3 (fr) | Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique | |
ATE372774T1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
BG105342A (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
EA200501223A1 (ru) | Терапевтическая система, содержащая амоксициллин и клавулановую кислоту | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
DK1492539T3 (da) | Statin-terapi til forögelse af kognitiv funktion | |
NO984651L (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
SE9800905L (sv) | Ny terapi vid glomerulonefrit | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1037629 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |